Lymphoma

 

Rituximab + Lenalidomide vs Chemotherapy (RELEVANCE-7636)
A Phase 3 Open-Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma. The "RELEVANCE" Trial (Rituximab Lenalidomide Versus Any Chemotherapy)

Investigator: Edward N. Libby, MD;   Conditions: Follicular Lymphoma;    Status: Recruiting;   Study ID: NCT01476787

SGN-35 w/ CHOP for Anaplastic Large Cell Lymphoma
A Phase 1 Study of Brentuximab Vedotin Administered Sequentially and Concurrently With Multi-Agent Chemotherapy as Front-Line Therapy in Patients With Systemic Anaplastic Large Cell Lymphoma

Investigator: Andrei Shustov, M.D.;   Conditions: Anaplastic Large-Cell Lymphoma;    Status: Recruiting;   Study ID: NCT01309789

PF-04449913 for Hematologic Malignancies (B1371001)
A Phase 1 Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF 04449913, An Oral Hedgehog Inhibitor, Administered As Single Agent In Select Hematologic Malignancies

Investigator: Vivian Oehler, M.D,;   Conditions: Hematologic Malignancies;    Status: Recruiting;   Study ID: NCT00953758

Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma (6914)
A Phase II Prospective Non-Randomized Two-Arm Clinical Trial of Dose-Adjusted Schedule of Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma (CTCL) Who Did Not Receive Prior Systemic Therapy

Investigator: Andrei Shustov, MD;   Conditions: Cutaneous T-cell Non-Hodgkin Lymphoma;    Status: Recruiting;   Study ID: NCT00958074

F 18-PET/CT Imaging for Stage III-IV Hodgkin's (SWOG 0816)
A Phase II Trial of Response-Adapted Therapy of Stage III-IV Hodgkin Lymphoma Using Early Interim FDG-PET Imaging

Investigator: Oliver W. Press, MD, PhD;   Conditions: Lymphoma;    Status: Recruiting;   Study ID: NCT00822120

Chemo Based on PET Scan for Stage I-II Hodgkin Lymphoma (CTSU C50604)
Phase II Trial Of Response-Adapted Chemotherapy Based On Positron Emission Tomography For Non-Bulky Stage I And II Hodgkin Lymphoma

Investigator: Fred Appelbaum, MD;   Conditions: Hodgkin's Lymphoma;    Status: Recruiting;   Study ID: NCT01132807

Vorinostat and Combination Chemotherapy With Rituximab for HIV-Related Lymphoma (2483)
A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy With Rituximab in HIV-Related B-cell Non-Hodgkin's Lymphoma

Investigator: Ann Woolfrey, MD;   Conditions: Lymphoma;    Status: Recruiting;   Study ID: NCT01193842